中西医结合治疗溃疡性结肠炎的临床研究
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金项目(编号:30772801)——结肠粘膜中性粒细胞凋亡延迟机制及清肠栓调控作用


Clinical Study of Yunnan Hongyao Capsule in the Treatment of Ulcerative Colitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察云南红药胶囊治疗溃疡性结肠炎的临床疗效。方法:采用随机对照研究方法,60例溃疡性结肠炎患者随机分为治疗组及对照组,分别给予云南红药胶囊联合美沙拉嗪缓释颗粒剂口服及单独应用美沙拉嗪缓释颗粒剂,疗程4周。结果:云南红药胶囊可明显改善溃疡性结肠炎患者腹痛、腹泻、黏液脓血便、里急后重等临床症状,减少患者大便常规红细胞及白细胞,减轻患者肠黏膜损伤,总有效率90%,与单独口服美沙拉嗪缓释颗粒剂比较有统计学意义。结论:云南红药胶囊治疗溃疡性结肠炎,疗效满意,无严重不良反应,值得临床推广。

    Abstract:

    To observe the clinical efficacy of Yunnan Hongyao capsule in the treatment of ulcerative colitis.Methods:Using randomized study method,60 cases of ulcerative colitis were randomly divided into treatment group and control group,were given Yunnan Hongyao capsule combined with the beauty of salad and glipizide sustained-release granule oral sustained-release granules of salad for 4 weeks.Results:Yunnan Hongyao capsule can obviously improve the patients with ulcerative colitis with abdominal pain,diarrhea,bloody purulent stool,tenesmus and other clinical symptoms,reduce patient stool red blood cells and white blood cells,reduce intestinal mucosal injury,the total efficiency of 90%,there was significant difference compared with the single oral beauty of salad sustained-release granule.Conclusion:The effect of Yunnan Hongyao capsule in the treatment of ulcerative colitis,with no serious adverse reactions,it is worthy of clinical promotion.

    参考文献
    相似文献
    引证文献
引用本文

左振魁,韩佳瑞.中西医结合治疗溃疡性结肠炎的临床研究[J].世界中医药,2017,(06).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2017-04-10
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-06-28
  • 出版日期:
文章二维码